Page 3 - Life Sciences Tech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Tech Today - Breaking & Trending Today

Sisk appointed to Astellas Pharma €330M state-of-the art facility in Co. Kerry | Irish Building Magazine.ie | Ireland's Leading Construction News & Information Portal

Published: March 26, 2024

Sisk has announced that it has been awarded the contract as Construction Manager for a major new pharmaceutical facility in Tralee, Co. Kerry. The €330m fill-finish production facility will be constructed on the IDA’s greenfield site at the Kerry Technology Park. The project is to create 600 construction jobs over the course of the build,

Source: irishbuildingmagazine.ie

AERIS PARTNERS LAUNCHES NEW SAN FRANCISCO OFFICE; HIRES GRAY EKLUND TO HELP DRIVE WEST COAST EXPANSION

Published: September 6, 2022

/PRNewswire/ -- Aeris Partners LLC ("Aeris Partners" or "Aeris"), a leading technology M&A investment bank, is excited to announce the launch of its new San...

Source: prnewswire.com

Asia-Pacific Healthcare AI Market Outlook to 2025: Focus on IBM, NVIDIA, Intel, Microsoft, iCarbonX, Alphabet, Next IT Verint, Welltok, Oncora Medical, Entilic, Koninklijke Philips and General Vision

Published: February 3, 2021

Share this article Share this article ResearchAndMarkets.com's offering. This report will particularly help the readers to identify the ongoing trends in the industry and anticipated growth in the future depending upon changing industry dynamics in upcoming years. The report also covers emerging growth drivers and trends; innovation, adoption and application gap in comparison to US and Europe; case studies on various healthcare application areas and competitive landscape of players in the market with special focus on IBM, NVIDIA Corporation, Intel, Microsoft Corporation, iCarbonX, Alphabet I...